Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study

NCT02654470 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02654470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
July 16, 2019
Completion date
September 28, 2021
Enrollment
300 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation